Actively Recruiting
Managing Cancer and Living Meaningfully (CALM) Adapted to Italian Cancer Care Setting
Led by Università degli Studi di Ferrara · Updated on 2024-07-03
171
Participants Needed
1
Research Sites
320 weeks
Total Duration
On this page
Sponsors
U
Università degli Studi di Ferrara
Lead Sponsor
P
Princess Margaret Hospital, Canada
Collaborating Sponsor
AI-Summary
What this Trial Is About
Background: Patients with advanced cancer suffer from a variety of psycho-social symptoms that impair quality of life and may benefit from psychotherapeutic treatment. We describe here the methodology of a randomized controlled trial to test the effectiveness of a novel and brief semi-structured psychotherapeutic intervention, called Managing Cancer and Living Meaningfully (CALM), originally developed in Canada and now cross-culturally tested in Italy. Methods/Design: The study is a single-blinded randomized controlled trial with 2 conditions: CALM intervention versus nonspecific supportive intervention (SPI) and assessments at baseline, 3 and 6 months. The coordinating site is the Program on Psycho-Oncology and Psychiatry in Palliative Care, University of Ferrara and Integrated Department of Mental Health, S. Anna University Hospital, in Ferrara, Italy. Another centre from northern and southern Italy will collaborate. Eligibility criteria include: ≥ 18 years of age; Italian fluency; no cognitive impairment; and diagnosis of advanced cancer. The intervention consists of 12 sessions , following the CALM manual and allowing for flexibility to meet individual patients' needs. It is delivered over a 6-month period and provides reflective space for patients (and their primary caregivers) to address 4 main domains: symptom management and communication with health care providers; changes in self and relations with close others; sense of meaning and purpose; and the future and mortality. The primary outcome is depression and the primary endpoint is at 6 months. Secondary outcomes include demoralization, generalized anxiety, death anxiety, spiritual well-being, quality of life, attachment security, posttraumatic growth, communication with partners, and satisfaction with clinical interactions. Discussion: This trial is being conducted to determine the effectiveness of CALM in an Italian cancer setting. The intervention has potential cross-national relevance and, if shown to be effective, has the potential to be disseminated as a new approach in oncology to relieve distress and promote psychological well-being in patients with advanced cancer.
CONDITIONS
Official Title
Managing Cancer and Living Meaningfully (CALM) Adapted to Italian Cancer Care Setting
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 18 years of age or more
- Fluency in Italian language
- No cognitive impairment
- Diagnosis of advanced cancer (specific stages of lung, pancreatic, ovarian, gynecological, breast, genitourinary, gastrointestinal, melanoma, sarcoma, or endocrine cancers) with expected survival of 12-18 months
- Score of 10 or higher on the Patient Health Questionnaire or 20 or higher on the Death and Dying Distress Scale
You will not qualify if you...
- Communication difficulties that hinder psychotherapy
- Inability to commit to the required 12 therapy sessions
- Currently receiving psychotherapy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Università di Ferrara
Ferrara, Emilia-Romagna, Italy, 44100
Actively Recruiting
Research Team
L
Luigi Grassi, M.D.
CONTACT
R
Rosangela Caruso, M.D., PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here